Dr. Smith discussed the assessment of bulbar function in ALS clinical trials at Biogen Pharmaceuticals (Boston), at the ALS Investigator Research Workshop sponsored by ALSA (Philadelphia), and again in Clearwater, Florida at the NEALS annual meeting.
top of page
bottom of page